# AMRIX
> **NDA021777** · New Drug Application · Sponsor: TEVA PHARMS INTL · Approved 2007-02-01
## Drug
- **FDA Application Number:** NDA021777
- **Application type:** New Drug Application
- **Brand name:** AMRIX
- **Generic name:** CYCLOBENZAPRINE HYDROCHLORIDE
- **Active ingredients:** CYCLOBENZAPRINE HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS INTL
- **Manufacturer:** Amneal Pharmaceuticals of New York LLC
- **First approval:** 2007-02-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021777)
---
*AI Analytics · CC0 1.0*